ArticleCarcinogenesis2012

MicroRNA-1826 directly targets beta-catenin (CTNNB1) and MEK1 (MAP2K1) in VHL-inactivated renal cancer.

Hiroshi Hirata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.